BASILEA PHARMACEUTICA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA PHARMACEUTICA Trademark

Serial Number: 90269990

BASILEA PHARMACEUTICA is a trademark filed by BASILEA PHARMACEUTICA INTERNATIONAL LTD. on October 21, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BASILEA PHARMACEUTICA INTERNATIONAL LTD. (19 trademarks)

GRENZACHERSTRASSE 487
BASEL CH-4005 , CH

Entity Type: 03

BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (27 trademarks)

HEGENHEIMERMATTWEG 167B
ALLSCHWIL 4123 , CH

Entity Type: 03

Trademark Details

Filing Date

October 21, 2020

Registration Date

Not Registered

Published for Opposition

May 4, 2021

Goods & Services

Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 5, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 5, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 10, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 10, 2024 AITU
SOU EXTENSION 5 FILED
Dec 19, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 28, 2023 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jun 20, 2023 EX4G
SOU EXTENSION 4 FILED
Jun 20, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2022 EXRA
SOU EXTENSION 3 GRANTED
Dec 5, 2022 EX3G
SOU EXTENSION 3 FILED
Dec 5, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 5, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jun 20, 2022 EX2G
SOU EXTENSION 2 FILED
Jun 20, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 20, 2022 EEXT
ASSIGNED TO EXAMINER
May 27, 2022 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 4, 2021 EXRA
SOU EXTENSION 1 GRANTED
Dec 2, 2021 EX1G
SOU EXTENSION 1 FILED
Dec 2, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 2, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 29, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2020 NWOS
NEW APPLICATION ENTERED
Oct 24, 2020 NWAP